Swiss National Bank Grows Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Swiss National Bank lifted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) by 0.9% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 202,368 shares of the company’s stock after acquiring an additional 1,900 shares during the quarter. Swiss National Bank owned approximately 0.22% of Acadia Healthcare worth $14,228,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Acadia Healthcare by 1.5% during the third quarter. Vanguard Group Inc. now owns 8,758,004 shares of the company’s stock worth $684,700,000 after acquiring an additional 131,959 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Acadia Healthcare by 0.5% in the second quarter. JPMorgan Chase & Co. now owns 3,361,534 shares of the company’s stock worth $267,713,000 after acquiring an additional 15,177 shares during the last quarter. William Blair Investment Management LLC raised its position in shares of Acadia Healthcare by 19.8% in the 2nd quarter. William Blair Investment Management LLC now owns 3,048,854 shares of the company’s stock worth $242,811,000 after purchasing an additional 504,572 shares during the last quarter. State Street Corp boosted its stake in Acadia Healthcare by 0.9% in the 2nd quarter. State Street Corp now owns 2,563,638 shares of the company’s stock worth $204,168,000 after purchasing an additional 22,019 shares in the last quarter. Finally, Durable Capital Partners LP grew its position in Acadia Healthcare by 30.8% during the 4th quarter. Durable Capital Partners LP now owns 1,941,595 shares of the company’s stock valued at $159,832,000 after purchasing an additional 457,687 shares during the last quarter.

Analyst Upgrades and Downgrades

ACHC has been the topic of a number of recent analyst reports. Royal Bank of Canada cut their price target on shares of Acadia Healthcare from $99.00 to $94.00 and set an “outperform” rating on the stock in a report on Tuesday, November 7th. TheStreet downgraded shares of Acadia Healthcare from a “b” rating to a “c” rating in a report on Friday, November 3rd. Finally, Stephens upgraded Acadia Healthcare from an “equal weight” rating to an “overweight” rating and set a $92.00 price objective for the company in a research report on Friday, January 5th. One analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $84.83.

Get Our Latest Stock Report on ACHC

Acadia Healthcare Stock Up 2.3 %

NASDAQ ACHC opened at $82.06 on Monday. Acadia Healthcare Company, Inc. has a 52 week low of $66.49 and a 52 week high of $87.39. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $7.57 billion, a P/E ratio of -390.76, a price-to-earnings-growth ratio of 1.89 and a beta of 1.33. The stock’s 50-day moving average price is $79.72 and its 200-day moving average price is $75.89.

Insider Buying and Selling

In other Acadia Healthcare news, Director Debra K. Osteen sold 8,000 shares of Acadia Healthcare stock in a transaction that occurred on Tuesday, December 12th. The shares were sold at an average price of $76.23, for a total transaction of $609,840.00. Following the transaction, the director now owns 710,833 shares of the company’s stock, valued at $54,186,799.59. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Acadia Healthcare news, Director Debra K. Osteen sold 8,000 shares of the firm’s stock in a transaction dated Tuesday, December 12th. The stock was sold at an average price of $76.23, for a total transaction of $609,840.00. Following the sale, the director now directly owns 710,833 shares of the company’s stock, valued at $54,186,799.59. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP John S. Hollinsworth sold 92,500 shares of the company’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $74.01, for a total value of $6,845,925.00. Following the completion of the transaction, the executive vice president now directly owns 84,630 shares of the company’s stock, valued at approximately $6,263,466.30. The disclosure for this sale can be found here. 2.80% of the stock is currently owned by insiders.

About Acadia Healthcare

(Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. It offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, eating disorder facilities, and outpatient clinics.

Featured Stories

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.